PERRIGO Co plc PRGO

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $13.05
Market Cap $1.78B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-2.8% YoY
$4.25B
3-Yr CAGR: -1.5%
Net Income ↓-729.7% YoY
-$1.43B
Net Margin: -33.5%
Free Cash Flow ↓-40.7% YoY
$145.10M
FCF Yield: 8.17%
EPS (Diluted) ↓-723.2% YoY
$-10.29
Basic: $-10.29
Return on Equity Efficiency
-48.6%
ROA: -616.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (PRGO)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $5,280.6M $2,051.8M $-4,012.8M $-28.01 $654.9M $548.7M
FY 2017 $4,946.2M -6.3% $1,979.5M $119.6M +103.0% $0.84 +103.0% $698.9M $610.3M +11.2%
FY 2018 $4,731.7M -4.3% $1,831.5M $131.0M +9.5% $0.95 +13.1% $593.0M $490.4M -19.6%
FY 2019 $4,837.4M +2.2% $1,773.3M $146.1M +11.5% $1.07 +12.6% $387.8M $250.1M -49.0%
FY 2020 $5,063.3M +4.7% $1,815.2M $-162.6M -211.3% $-1.19 -211.2% $636.2M $465.8M +86.2%
FY 2021 $4,138.7M -18.3% $1,416.2M $-68.9M +57.6% $-0.52 +56.3% $156.3M $4.2M -99.1%
FY 2022 $4,451.6M +7.6% $1,455.4M $-140.6M -104.1% $-1.04 -100.0% $307.3M $210.9M +4,921.4%
FY 2023 $4,655.6M +4.6% $1,680.4M $-12.7M +91.0% $-0.09 +91.3% $405.5M $303.8M +44.0%
FY 2024 $4,373.4M -6.1% $1,542.7M $-171.8M -1,252.8% $-1.25 -1,288.9% $362.9M $244.6M -19.5%
FY 2025 $4,253.1M -2.8% $1,494.5M $-1,425.4M -729.7% $-10.29 -723.2% $238.5M $145.1M -40.7%
$

Valuation

Market Price $13.05
Market Cap $1.78B
Enterprise Value $4.81B
P/E Ratio N/A
P/B Ratio 0.62
FCF Yield 8.17%
Dividend Yield 8.89%
Shares Outstanding 138,367,800
%

Profitability & Margins

Gross Margin 35.14%
Operating Margin -26.39%
Net Margin -33.51%
Return on Equity (ROE) -48.56%
Return on Assets (ROA) -615.99%
Asset Turnover 18.38x
Revenue 3-Yr CAGR -1.51%
🛡️

Financial Health & Liquidity

Current Ratio 0.23
Cash Ratio 0.59
Debt / Equity 1.240
Debt / Assets 15.731
Cash & Equivalents $600.70M
Total Debt $3.64B
Book Value / Share $21.22
💧

Cash Flow Efficiency

Operating Cash Flow $238.50M
Capital Expenditures (CapEx) $93.40M
Free Cash Flow $145.10M
OCF / Revenue 5.61%
FCF / Revenue 3.41%
FCF 3-Yr CAGR -11.72%
🏷️

Per Share Metrics

EPS (Diluted) $-10.29
EPS (Basic) $-10.29
Dividends / Share $1.16
Book Value / Share $21.22
EPS YoY Growth -723.20%
🏛️

Balance Sheet (FY 2025)

Total Assets $231.40M
Total Liabilities $1.01B
Stockholders' Equity $2.94B
Current Assets $231.40M
Current Liabilities $1.01B